| H - Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins | This group comprises all hormonal preparations for systemic use, except:
- Insulins, see A10.
- Anabolic steroids, see A14.
- Catecholamines, see C01C and R03C.
- Sex hormones, see G03.
- Sex hormones used in treatment of neoplastic diseases, see L02.
- Metreleptin used for treatment of complications of leptin deficiency in patients with generalised lipodystrophy is classified in A16AA.
| The DDDs are generally based on the treatment or diagnosis of endocrine disorders.
|
| | H01 - Pituitary and Hypothalamic Hormones and Analogues | | |
| | H01C - Hypothalamic Hormones | This group comprises hypothalamic hormones; extracts, purified natural hormones and synthetic analogues.
Hypothalamic hormones used as diagnostic agents for pituitary function are classified in V04CD.
|
| | H01CA - Gonadotropin-Releasing Hormones | Buserelin, goserelin, histrelin, leuprorelin, and triptorelin are classified in L02AE Gonadotropin releasing hormone analogues.
Gonadorelin used as diagnostic agent is classified in V04CM.
| The DDD of nafarelin is based on the treatment of endometriosis. No other DDDs have been assigned, due to the highly variable dosages used.
|
|
|
